Literature DB >> 20807325

Erectile dysfunction in young non-obese type II diabetic Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177.

Fernando S Carneiro1, Fernanda R C Giachini, Zidonia N Carneiro, Victor V Lima, Adviye Ergul, R Clinton Webb, Rita C Tostes.   

Abstract

INTRODUCTION: Diabetes mellitus (DM) is a risk factor for erectile dysfunction (ED). Although type 2 DM is responsible for 90-95% diabetes cases, type 1 DM experimental models are commonly used to study diabetes-associated ED. AIM: Goto-Kakizaki (GK) rat model is relevant to ED studies since the great majority of patients with type 2 diabetes display mild deficits in glucose-stimulated insulin secretion, insulin resistance, and hyperglycemia. We hypothesized that GK rats display ED which is associated with decreased nitric oxide (NO) bioavailability.
METHODS: Wistar and GK rats were used at 10 and 18 weeks of age. Changes in the ratio of intracavernosal pressure/mean arterial pressure (ICP/MAP) after electrical stimulation of cavernosal nerve were determined in vivo. Cavernosal contractility was induced by electrical field stimulation (EFS) and phenylephrine (PE). In addition, nonadrenergic-noncholinergic (NANC)- and sodium nitroprusside (SNP)-induced relaxation were determined. Cavernosal neuronal nitric oxide synthase (nNOS) and endothelial nitric oxide synthase (eNOS) mRNA and protein expression were also measured. MAIN OUTCOME MEASURE: GK diabetic rats display ED associated with decreased cavernosal expression of eNOS protein.
RESULTS: GK rats at 10 and 18 weeks demonstrated impaired erectile function represented by decreased ICP/MAP responses. Ten-week-old GK animals displayed increased PE responses and no changes in EFS-induced contraction. Conversely, contractile responses to EFS and PE were decreased in cavernosal tissue from GK rats at 18 weeks of age. Moreover, GK rats at 18 weeks of age displayed increased NANC-mediated relaxation, but not to SNP. In addition, ED was associated with decreased eNOS protein expression at both ages.
CONCLUSION: Although GK rats display ED, they exhibit changes in cavernosal reactivity that would facilitate erectile responses. These results are in contrast to those described in other experimental diabetes models. This may be due to compensatory mechanisms in cavernosal tissue to overcome restricted pre-penile arterial blood supply or impaired veno-occlusive mechanisms.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807325      PMCID: PMC3022479          DOI: 10.1111/j.1743-6109.2010.02000.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  58 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats.

Authors:  Tsuneo Kobayashi; Takayuki Matsumoto; Kazuyuki Ooishi; Katsuo Kamata
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-06       Impact factor: 4.733

3.  Determination of adenosine effects and adenosine receptors in murine corpus cavernosum.

Authors:  Rita C Tostes; Fernanda R C Giachini; Fernando S Carneiro; Romulo Leite; Edward W Inscho; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2007-05-09       Impact factor: 4.030

Review 4.  Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors.

Authors:  Raymond C Rosen; Rena Wing; Stephen Schneider; Noel Gendrano
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 5.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

Authors:  N E Cameron; S E Eaton; M A Cotter; S Tesfaye
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

6.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

7.  Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici.

Authors:  D Fedele; A Bortolotti; C Coscelli; F Santeusanio; L Chatenoud; E Colli; M Lavezzari; M Landoni; F Parazzini
Journal:  Int J Epidemiol       Date:  2000-06       Impact factor: 7.196

8.  Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes.

Authors:  S Jesmin; I Sakuma; A Salah-Eldin; K Nonomura; Y Hattori; A Kitabatake
Journal:  J Mol Endocrinol       Date:  2003-12       Impact factor: 5.098

Review 9.  Animal models in type 2 diabetes research: an overview.

Authors:  K Srinivasan; P Ramarao
Journal:  Indian J Med Res       Date:  2007-03       Impact factor: 2.375

10.  Elevation of intracavernous pressure and NO-cGMP activity by a new herbal formula in penile tissues of aged and diabetic rats.

Authors:  Chang-Shin Park; Seung-Duk Ryu; Sung-Yeoun Hwang
Journal:  J Ethnopharmacol       Date:  2004-09       Impact factor: 4.360

View more
  13 in total

1.  Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 diabetic men with erectile dysfunction.

Authors:  B Musicki; A L Burnett
Journal:  Andrology       Date:  2017-01-11       Impact factor: 3.842

Review 2.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

3.  Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.

Authors:  Hicham Labazi; Brandi M Wynne; Rita Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2013-07-24       Impact factor: 3.802

4.  Internal pudendal artery from type 2 diabetic female rats demonstrate elevated endothelin-1-mediated constriction.

Authors:  Kyan J Allahdadi; Johanna L Hannan; Adviye Ergul; Rita C Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2011-06-30       Impact factor: 3.802

5.  Penile constitutive nitric oxide synthase expression in rats exposed to unpredictable chronic mild stress: role of inflammation.

Authors:  T D Şahin; Y Yazır; T Utkan; S S Göçmez; D Bayramgürler
Journal:  Int J Impot Res       Date:  2016-12-01       Impact factor: 2.896

6.  The use of animal models in diabetes research.

Authors:  Aileen J F King
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

7.  EXPERIMENTAL INDUCTION OF TYPE 2 DIABETES MELLITUS AND THE EFFICIENCY OF BARIATRIC SURGERY IN ITS REVERSAL IN RATS.

Authors:  L D Hritcu; D Borcea; E Anton; S Morosan; S Pasca; C Trinca; M C Spataru; F D Petrariu; L C Burtan; A Ciobica; A Curpan; D Timofte
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

8.  The impact of diabetes mellitus on penile length in men undergoing inflatable penile prosthesis implantation.

Authors:  Yiğit Akın; İlker Fatih Şahiner; Mustafa Faruk Usta
Journal:  Turk J Urol       Date:  2013-09

9.  Erectile dysfunction precedes coronary artery endothelial dysfunction in rats fed a high-fat, high-sucrose, Western pattern diet.

Authors:  Justin D La Favor; Ethan J Anderson; Robert C Hickner; Christopher J Wingard
Journal:  J Sex Med       Date:  2012-11-21       Impact factor: 3.802

10.  Role of neural NO synthase (nNOS) uncoupling in the dysfunctional nitrergic vasorelaxation of penile arteries from insulin-resistant obese Zucker rats.

Authors:  Ana Sánchez; Cristina Contreras; María Pilar Martínez; Belén Climent; Sara Benedito; Albino García-Sacristán; Medardo Hernández; Dolores Prieto
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.